These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2515981)

  • 1. Prodrug derivatives of thyrotropin-releasing hormone and other peptides.
    Bundgaard H; Møss J
    Biochem Soc Trans; 1989 Oct; 17(5):947-9. PubMed ID: 2515981
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolites of thyrotropin releasing hormone inhibit angiotensin converting enzyme in vitro.
    MacGregor JS; Resnick LM; Laragh JH
    Biochem Biophys Res Commun; 1982 Nov; 109(2):556-61. PubMed ID: 6295402
    [No Abstract]   [Full Text] [Related]  

  • 3. An analogue of thyrotropin releasing hormone with improved biological stability both in vitro and in vivo.
    Brewster D; Rance MJ
    Biochem Pharmacol; 1980 Oct; 29(19):2619-23. PubMed ID: 6775640
    [No Abstract]   [Full Text] [Related]  

  • 4. Forces and structural limitations of binding of thyrotrophin-releasing factor to the thyrotrophin-releasing receptor: the pyroglutamic acid moiety.
    Goren HJ; Bauce LG; Vale W
    Mol Pharmacol; 1977 Jul; 13(4):606-14. PubMed ID: 196172
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of repeated administration of a long acting TRH analogue (RX77368), on TSH, T4, T3 and prolactin in patients with motor neuron disease.
    Eckland DJ; Modarres-Sadeghi H; Lightman SL; Guiloff RJ
    J Neurol Neurosurg Psychiatry; 1990 Sep; 53(9):803-4. PubMed ID: 2123237
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis of the phosphinic analogue of thyrotropin releasing hormone.
    Matziari M; Bauer K; Dive V; Yiotakis A
    J Org Chem; 2008 Nov; 73(21):8591-3. PubMed ID: 18826326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRH analogue with C-terminal thioamide group. Synthesis, receptor binding, TSH-releasing activity and alpha-MSH-releasing activity.
    Kruszyński M; Kupryszewski G; Ragnarsson U; Alexandrova M; Strbak V; Tonon MC; Vaudry H
    Experientia; 1985 Dec; 41(12):1576-7. PubMed ID: 3000815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropharmacodynamic evaluation of the centrally active thyrotropin-releasing hormone analogue [Leu2]TRH and its chemical brain-targeting system.
    Prokai L; Zharikova AD
    Brain Res; 2002 Oct; 952(2):268-74. PubMed ID: 12376188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentrations of thyrotropin-releasing hormone (TRH) and deamido-TRH, and TRH deamidase activity in brain.
    Emerson CH; Vogel W; Currie BL
    Endocrinology; 1980 Aug; 107(2):443-9. PubMed ID: 6771121
    [No Abstract]   [Full Text] [Related]  

  • 10. TRH and amyotrophic lateral sclerosis.
    Griffiths EC
    Neurology; 1987 Jan; 37(1):175-6. PubMed ID: 3099228
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuroendocrine effects of thyroliberin and its analogs.
    Babichev VN; Samsonova VM; Airapetyants MG; Kolomeitseva IA; Shvachkin YuP ; Smirnova AP
    Neurosci Behav Physiol; 1982; 12(5):394-7. PubMed ID: 6820125
    [No Abstract]   [Full Text] [Related]  

  • 12. Intrathecal substance P and galanin attenuate TRH analogue-induced wet-dog shake behaviour.
    Dixon DM; Fone KC; Bennett GW; Marsden CA
    Br J Pharmacol; 1989 Dec; 98 Suppl():829P. PubMed ID: 2482111
    [No Abstract]   [Full Text] [Related]  

  • 13. Thyrotrophin-releasing hormone. New applications in the clinic.
    Griffiths EC
    Nature; 1986 Jul 17-23; 322(6076):212-3. PubMed ID: 3090448
    [No Abstract]   [Full Text] [Related]  

  • 14. Electrophysiological observations in patients with motor neuron disease receiving a thyrotropin releasing hormone analogue (RX77368).
    Guiloff RJ; Stålberg E; Eckland DJ; Lightman SL
    J Neurol Neurosurg Psychiatry; 1987 Dec; 50(12):1633-40. PubMed ID: 3125307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of a series of residue 1 (pyroglutamic acid) analogs of thyrotrophin releasing hormone.
    Bauce LG; Goren HJ
    Int J Pept Protein Res; 1979; 14(3):216-26. PubMed ID: 118133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A thyrotropin-releasing hormone analogue: pGlu-Phe-D-Pro-psi [CN4]-NMe at 293 and 107 K.
    Howell PL; Pangborn WA; Marshall GR; Zabrocki J; Smith GD
    Acta Crystallogr C; 1995 Dec; 51 ( Pt 12)():2575-9. PubMed ID: 8588858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is thyrotropin releasing hormone an endogenous ergotropic substance in the brain?
    Metcalf G; Dettmar PW
    Lancet; 1981 Mar; 1(8220 Pt 1):586-9. PubMed ID: 6110823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation and degradation of deamido-TRH (pyroglutamyl-histidyl-proline) in rat brain after intraventricular injection of TRH.
    Spindel ER; Lakher M; Wurtman RJ
    Brain Res; 1981 Jul; 216(2):343-50. PubMed ID: 6788347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotropin-releasing hormone analogue and serotonin interact within the dorsal vagal complex to augment gastric acid secretion.
    McTigue DM; Rogers RC; Stephens RL
    Neurosci Lett; 1992 Sep; 144(1-2):61-4. PubMed ID: 1436715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The involvement of central cholinergic mechanisms in cardiovascular responses to intracerebroventricular and intravenous administration of thyrotropin-releasing hormone.
    Okuda C; Mizobe T; Miyazaki M
    Life Sci; 1987 Mar; 40(13):1293-9. PubMed ID: 3104710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.